Person Overview




Risa Stack joined Kleiner Perkins Caufield & Byers in 2003. Risa specializes in the development of life science companies. She was the founding CEO and is currently a board member of several companies including CardioDx, Nodality, and an incubation in the personalized medicine area. She is currently on the BoD of Corthera and Trius and a board observer at Codon Devices, Xdx, Orexigen (OREX), Tethys, and Pacific Biosciences.

Prior to joining KPCB, Risa was a Principal at J.P. Morgan Partners in the life science practice for 6 years. While at J.P. Morgan Partners she sponsored a series of investments including Acurian, AlgoRx (now Anesiva), Connetics, Diatide, Ilex Oncology, Illumina, Praecis Pharmaceuticals and Triangle Pharmaceuticals.

Prior to working in the venture capital industry, Risa worked as a Derivative Specialist on the Chicago Board of Trade where she traded futures and options on government... See More